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Background: Postmastectomy breast reconstruction (PMBR) is an elective, prefer-
ence-sensitive decision made during a stressful, time-pressured period after a can-
cer diagnosis. Shared decision making (SDM) can improve decision quality about 
preference-sensitive choices. Stakeholders’ perspectives on ways to support PMBR 
decision-making were explored.
Methods: Forty semi-structured interviews with stakeholders (20 postmastectomy 
patients, 10 PMBR surgeons, 10 PMBR nurses) were conducted. Clinicians were 
recruited from diverse practices across the United States. Patients were recruited 
using purposive sampling with varying PMBR experiences, including no reconstruc-
tion. The interview guide was based on an implementation research framework. 
Themes were identified using grounded theory approach, based on frequency and 
emotive force conveyed.
Results: Engagement in SDM was variable. Some patients wanted more infor-
mation about PMBR from clinicians, particularly about risks. Some clinicians 
acknowledged highlighting benefits and downplaying risks. Many patients felt 
pressured to make a choice by their clinicians. Clinicians who successfully en-
gaged patients through decisions often used outside resources to supplement 
conversations.
Conclusions: Patient–clinician trust was critical to high-quality decisions, and many 
patients expressed decision regret when they were not engaged in PMBR discus-
sions. Patients often perceived a race- or age-related bias in clinician information 
sharing. Interventions to support SDM may enhance decision quality and reduce 
decision regret about PMBR, ultimately improving patient-centered care for wom-
en with breast cancer. (Plast Reconstr Surg Glob Open 2017;5:e1569; doi: 10.1097/
GOX.0000000000001569; Published online 13 November 2017.)
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INTRODUCTION
Breast cancer is the most common noncutaneous can-
cer among women in the United States.1 Universal cov-
erage for postmastectomy breast reconstruction (PMBR) 
has led to a steady increase in its utilization among breast 
cancer patients.2 PMBR can improve quality of life, psy-
chosocial and sexual well-being.3–5 However, it also comes 
with significant risks.6–10 As many as half of all PMBR pa-
tients may experience wound complications and up to 
one-quarter may experience complications severe enough 
to require additional surgeries.6,11
PMBR is an elective, preference-sensitive decision made 
during a stressful, time-pressured period after a cancer 
diagnosis. In order for patients to make high-quality deci-
sions that are both informed and preference-concordant, 
accurate information about reconstruction procedures, 
their alternatives, and potential outcomes is critical.12,13 Un-
fortunately, 70% of patients considering PMBR may have 
knowledge deficits regarding its risks and benefits.14 Fewer 
than half of the patients report making high-quality PMBR 
decisions that are informed and consistent with patient 
preferences.13 Furthermore, there may be racial disparities 
in PMBR knowledge and receipt of PMBR surgery.15,16 In-
adequate knowledge and choices inconsistent with prefer-
ences can lead to decisional regret, reduced quality of life, 
and secondary, costly procedures.17,18
To improve patient-centered care for women with 
breast cancer, additional research is needed on ways to 
support women’s preference-sensitive PMBR decisions. 
Shared decision making (SDM), a process of engaging pa-
tients in health decisions with multiple medically appropri-
ate treatment options, can improve decision quality about 
preference-sensitive choices especially when facilitated by 
decision aids (DAs).19,20 As a first step toward developing a 
DA for PMBR, this study sought to explore stakeholders’ 
perspectives on ways to support PMBR decision-making 
through a series of semi-structured qualitative interviews.
METHODS
Theoretical Framework
Interview guides for patients and clinicians were devel-
oped based on an implementation research framework,21 
as the ultimate goal of this work is to implement evidence-
based approaches to SDM for PMBR. Stakeholders were 
engaged to identify existing facilitators and barriers to 
SDM for PMBR. Qualitative interviews were conducted for 
this phase of the project to capture in-depth experiences 
and perspectives of stakeholders, consistent with our im-
plementation research framework. Qualitative research 
provides a foundation for understanding attitudes and 
beliefs about topics beyond what can be captured in quan-
titative surveys. It allowed stakeholders to openly discuss 
PMBR decisions from their own perspectives, rather than 
responding in ways driven by researchers. Results of this 
phase of the project will inform future work in a mixed-
methods approach to study PMBR decisions.
Interview guides were revised after obtaining feedback 
from experts in the field of SDM and breast reconstruc-
tion, and pilot testing with volunteer participants. Questions 
explored knowledge about SDM and DAs, preferences for 
PMBR, and experience with patient–clinician discussions 
about PMBR decisions. Interview guides are displayed in 
supplemental online material (see pdf, Supplemental Digital 
Content 1, which displays a interview guide for patient and 
clinician stakeholders, http://links.lww.com/PRSGO/A609).
Study Population and Recruitment
Stakeholders included postmastectomy patients, plastic 
surgeons who perform PMBR, and perioperative nursing 
staff who care for surgically treated breast cancer patients. 
Interviewers had no prior relationship with their interview-
ees. This study was approved by the Washington University 
Institutional Review Board and Siteman Cancer Center’s 
Protocol Review Management Committee. Stakeholders 
completed informed consent. After informal conversa-
tions with surgeons, it was determined that incentives for 
surgeons would not impact the study; given budgetary limi-
tations, only nurses and patients were remunerated for par-
ticipation. Semistructured interviews, ranging from 17 to 58 
minutes, were conducted between March and June 2017 by 
trained interviewers (J.H. and S.P.) supervised by an experi-
enced qualitative researcher (M.P.). Interviews were audio 
recorded and transcribed verbatim. Recruitment continued 
until thematic saturation was reached, based on standard 
approaches to sampling strategies in qualitative research.22
Patients
Patients were purposively sampled from a database of 
those who had undergone mastectomy between January 1, 
2016, and January 1, 2017, at 1 institution. Inclusion crite-
ria for patients were female, ≥ 18 years of age, mastectomy 
for breast cancer ≤ 5 years before enrollment, no metastat-
ic disease, could provide written consent in English, and 
completed surgery [as applicable: (1) formation of breast 
mound and symmetry procedure; (2) placement of nipple-
areola reconstruction in cases of skin-sparing mastectomy; 
(3) patients 1 year from surgery if they did not receive post-
operative chemotherapy, 18 months from surgery if they 
received postoperative chemotherapy, 2 years from surgery 
if they received radiation]. Some patients in the no recon-
struction group had been referred to reconstructive sur-
geons before deciding not to have reconstruction; others 
only saw a breast surgeon without referral.
A chart review of 135 patients was conducted to de-
termine agreement with enrollment criteria. Letters were 
sent to 81 participants to inform them of the study. We 
directly contacted 33 of those 81 patients based on their 
clinical characteristics, to achieve diversity in perspectives 
about reconstruction experiences. Of those, 20 agreed to 
participate, a 61% response rate of those contacted di-
rectly. African Americans were purposively overrecruited 
to explore preferences and perceived challenges when 
making PMBR decisions. Diversity in reconstructive expe-
rience (none, immediate/delayed, prosthetic/autologous 
reconstruction) was targeted (Table 1). All delayed recon-
struction patients chose this option initially; none were 
failed prior reconstruction patients. Participants were 
recruited using mailed letters and phone calls, eligibility 
 Hasak et al. • Breast Reconstruction Decision Making
3
was confirmed by phone, and interviews were scheduled 
by phone or in person, according to patient preference.
Clinicians
Plastic surgeons and nursing staff were enrolled using 
purposive and snowball sampling.23 Surgeons from various 
geographic areas in the United States and diverse practices 
(private/academic, rural/urban) were initially recruited 
via e-mail lists of national organizations. They could also 
refer us to others with expertise counseling patients about 
PMBR. Our goal was to recruit those across settings and geo-
graphic regions to provide a range of experiences. Nurses 
who treat breast reconstruction patients perioperatively or 
postoperatively were recruited via e-mail or in person from 
diverse areas of care at 1 academic institution. Inclusion cri-
teria for clinicians included the following: performs PMBR 
or involved in perioperative care of surgically treated breast 
cancer patients and able to provide written consent in Eng-
lish. Screening and interviews were completed by phone.
Data Analysis
Nvivo 11 software (QSR International Pty., Ltd.) was used 
to code transcripts. Transcripts were reviewed, and prelimi-
nary codebooks were developed based on emerging themes 
and interview guides. Two team members coded 5 patient 
interviews each (J.H. and V.G.) and 5 clinician interviews 
each (S.P. and V.G.). The coding process was discussed, 
and the codebook was refined. Coders came to consensus 
on inconsistent codes. If consensus could not be reached, a 
third coder (M.P.) was consulted. Once coders obtained in-
terrater reliability (kappa > 0.8; percent agreement > 97%), 
remaining transcripts were coded independently. Themes 
were identified using grounded theory approach,24 based 
on frequency of codes and emotive force conveyed.
RESULTS
Eighty-one potential patient participants were mailed 
letters; 33 of those mailed were also contacted by phone 
(15 answered). Nine enrolled from the mailed letters, 
and 11 who were reached by phone enrolled. Reasons for 
nonparticipation included transportation difficulties, not 
wanting to influence others by sharing experiences, and 
not wanting to relive experiences. Seventeen surgeons 
were contacted; 10 enrolled (58.8%). Fourteen nurses 
were contacted; 10 enrolled (71.4%). Clinicians cited time 
or scheduling constraints as reasons for nonparticipation.
A total of 40 interviews were conducted (20 patients, 
20 clinicians). Table 1 describes sample characteristics. 
 Table 2 outlines preexisting stakeholder knowledge of 
SDM and DAs.
The main themes that emerged from the data are de-
scribed below with illustrative quotes (P = patient, C = cli-
nician).
Theme 1: Engagement in SDM is variable.
Stakeholders discussed widely varying levels of prac-
tice of, or participation in, SDM. Some described a very 
patient-centered process of engagement for breast recon-
struction decisions.
“When I asked, ‘What would you suggest?’ He says, ‘I will 
give you all the support that you need, no matter what your 
decision is.’ That meant everything to me. He did not push 
me one way or the other. It was totally my decision how I 
wanted it done.” [P9, Delayed, autologous reconstruction]
“She said, ‘You can never ask too many questions.’ I said, 
‘Okay, well let me ask then.’ I kept asking and talking...
Whatever I feel comfortable with, she’s okay with...” [P18, 
Immediate, implant-based reconstruction]
 “…you need to know where your patient wants to head… 
If you don’t listen to what they want, then they’re not gon-
na be happy in the end.” [C11]
Table 1.  Characteristics of Study Sample (n = 40)
Characteristics
Number (% within Each 
Population)
Patient 20 (100)
  Race  
   African American 10 (50)
   White 10 (50)
  Age  
   30–40 5 (25)
   41–50 4 (20)
   51–60 3 (15)
   61–70 6 (30)
   71–80 2 (10)
  Reconstruction type  
   Autologous 7 (35)
   Implant 8 (40)
   None 5 (25)
  Reconstruction timing  
   Immediate 12 (60)
   Delayed 3 (15)
Clinician 20 total
Nurse 10 (100)
  Gender  
   Female 10 (100)
Physician 10 (100)
  Gender  
   Male 7 (70)
   Female 3 (30)
  U.S. Census Bureau Region*  
   Northeast 2 (20)
   Midwest 1 (10)
   South 3 (30)
   West 4 (40)
  Practice type  
   Academic 4 (40)
   Private 2 (20)
   Cancer center 3 (30)
   Nonacademic hospital 1 (10)
*Physicians were enrolled from 10 different states within these regions.
Table 2. Preexisting Stakeholder Knowledge of Concepts
Knowledge of Concept
Number (%)
Patient  
(n = 20)
Physician 
(n = 10)
Nurse  
(n = 10)
SDM    
  Full understanding 2 (10) 3 (30) 0 (0)
  Some understanding* 5 (25) 3 (30) 5 (50)
  Heard term† 3 (15) 2 (20) 1 (10)
  Not heard term 10 (50) 2 (20) 4 (40)
DA    
  Full understanding 0 (0) 1 (10) 0 (0)
  Some understanding* 5 (25) 3 (30) 1 (10)
  Heard term† 1 (5) 4 (40) 0 (0)
  Not heard term 14 (70) 2 (20) 9 (90)
*Mentions some of the components of the concept but not full understanding.
†Has heard the term but cannot articulate any understanding.
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However, many patients described feeling like they 
did not have a choice, even during this preference-sen-
sitive decision.
“All the decisions are his [plastic surgeon]. I don’t think I 
have any decisions at this point. It’s whatever he wants to 
do, and now, he’s gonna do it.” [P4, Immediate, autolo-
gous and implant-based reconstruction]
“I do not feel like it was a shared decision. I felt like I was put 
out there. I was given a cookie cutter plan... It wasn’t about 
me.” [P12, Immediate, implant-based reconstruction]
“Nobody told me I had an option…There was never a lot of 
discussion on the options.” [P19, no reconstruction]
Some clinicians corroborated patients’ sentiments 
about clinician-dominated discussions.
“I don’t think the patients are really capable…of really un-
derstanding what they want. I think that it’s our job to 
guide them.” [C10]
“Not necessarily that it’s pushed on them, but…It’s expect-
ed that you go there [to have reconstructive surgery]… I 
don’t know if they [patients] always know that they have 
the option to just say, ‘I just want the mastectomy.’” [C12]
Theme 2: Stakeholders described many barriers to 
SDM, including limited information-sharing, clinician 
pressure, and clinician biases.
When SDM was not occurring, patients frequently 
wanted much more information about breast recon-
struction, especially regarding the potential risks of 
complications.
“I was not aware of it [risk of implant-associated anaplastic 
large cell lymphoma]. We didn’t talk about that before those 
went in…the last thing you want from your cancer treatment 
is cancer.” [P16, Immediate, implant-based reconstruction]
“There was a lot I didn’t know. I didn’t research. I didn’t 
understand.” [P7, no reconstruction]
“Well, I thought it would just be, you know, just the recover-
ing pain. I didn’t think about, hey, it’s gonna mess with 
other muscles in your body. It’s gonna cause you not to be 
able to raise your arm.” [P4, Immediate, autologous and 
implant-based reconstruction]
Many clinicians acknowledged highlighting benefits 
and downplaying risks.
“Yeah. I do address these things…[but] sometimes I brush 
over it a little bit.” [C1]
“Pain, complications…I don’t really tell them about that.” 
[C10]
Patients often felt pressure from their clinicians to 
choose 1 option or another.
“I said [to my doctor], ‘Well, can I think about it? Can I call 
you?’ He said, ‘No, you have to make a decision’… When he 
told me you just have to [decide]…I said, ‘Okay, let’s do it.’” 
[P18, Immediate, implant-based reconstruction]
“He [plastic surgeon] said…’You’ve got to make the right 
decision here. We need to do both sides…Please, let’s do both 
sides!’” [P1, Immediate, implant-based reconstruction]
Clinicians also referenced leading patients toward an 
option.
“At the end of the day, we have to be doctors. I don’t hesitate 
to point the patient in the right direction where they need 
to go.” [C10]
“…those women have so much on their mind…I think it’s 
easier for us to guide them to something, rather than them 
choosing.” [C12]
Some patients felt that clinicians were biased in their 
presentation of options because of the patient’s age, race, 
or socioeconomic status.
“I would’ve gladly talked with somebody…about it 
[reconstruction]…but that never happened. I guess they 
[clinicians] felt like a woman my age, you don’t matter… I 
was a poor, old, black lady, and it didn’t matter whether I 
had one breast….” [P19, no reconstruction]
“…he [plastic surgeon] said, ‘Well, you’re old anyhow, so 
what difference does it make?’ Isn’t that cruel? Those were 
the words.” [P1, Immediate, implant-based reconstruction]
“I don’t mean to sound—how can I say this professionally? 
I can’t find as many African American women doin’ it 
[reconstructive surgery].” [P7, no reconstruction]
Lack of SDM often led to decision regret.
“I regret that I didn’t have both of them removed at the 
time. Had I known what I know now…I would’ve had 
both breasts removed.” [P7, no reconstruction]
“If I’d known…I’d probably have taken the fat from some-
where else…” [P2, Immediate, autologous reconstruction]
 “If anyone had actually explained to me about options, I 
possibly would have reconsidered a reconstruction.” [P19, 
no reconstruction]
 “I did not research…had I did, I’d’a never made this 
decision…I woulda made so many better choices… if I 
knew…” [P4, Immediate, autologous and implant-based 
reconstruction]
THEME 3: SDM WAS PARTICULARLY 
CHALLENGING WHEN PATIENTS AND 
CLINICIANS DISAGREED ABOUT THE BEST 
PMBR OPTION FOR A PATIENT. HOWEVER, 
THOSE WHO ENGAGED IN SDM DURING 
DISAGREEMENTS OFTEN ENDED UP WITH 
MORE SATISFIED PATIENTS.
 “Even being a [health professional], physicians intimidate 
me...I’m not one who’d speak up. I would probably switch doc-
tors…but they wouldn’t let me [switch]. It made me angry.” 
[P17, Delayed, autologous reconstruction]
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“I was just goin’ along, like, ‘Okay, okay.’ Then I didn’t get 
the results I wanted…now after what I’ve been through I 
would just say, ‘I would like to get a second opinion.’” [P21, 
Immediate, autologous and implant-based reconstruction]
“I said, ‘This is what I’ve been thinking about.’ She [the 
surgeon] was like, ‘Why?’…Again, don’t depend on them 
[clinicians] to tell you. You go do your research…” [P12, 
Immediate, implant-based reconstruction]
When challenges to SDM during times of disagree-
ment were overcome, SDM was an effective technique to 
provide patient centered care and increase patient satis-
faction.
“I was like, ‘No, we’re not doing that.’… he [plastic sur-
geon] was very understanding and open to it, and let me 
make the choice…He wasn’t mad or anything about it…I 
didn’t feel like he would hold it against me…He was very, 
very respectful of the response that I gave him…I think it 
was a really good decision. I’m very happy…” [P20, De-
layed, autologous reconstruction]
“…she [surgeon] told me all about the whole process of hav-
ing reconstructive surgery. I said no. No matter what she 
thought…she told me it was my decision...[when] I dis-
agreed with anything she said or recommended—she said, 
‘It’s up to you.’...I’m very happy with my decision.” [P15, 
no reconstruction]
“The bottom line is it’s your decision and if that’s what you 
choose to do that’s fine. Let’s just go over everything and 
make sure that you do know that I think this is the best 
option, but this [alternative] is what you chose, and that’s 
fine.” [C19]
Theme 4: Stakeholders described factors that facilitat-
ed SDM, including patient–clinician trust, time during and 
outside consultations, an engaged care team, and supple-
mental resources used outside of the clinic visit.
Patients who described trust in their clinicians felt de-
cision-making was a shared experience.
“Like I said, she [surgeon] was open. I could sit there and 
talk to her just, not only as a doctor but as a friend. She al-
ways listened. She always looked at you when you talk. That 
was so very important to me.” [P22, no reconstruction]
“…the surgeon was so great about explaining it. I just felt 
comfortable. I was actually feeling blessed that I had a sur-
geon… I could talk to and not be intimidated by.” [P17, 
Delayed, autologous reconstruction]
Additionally, availability of time for consideration of 
options was described as an enabler to SDM by all stake-
holders.
 “Nothing was held back. Anything I asked was answered. 
I got plenty of time which was important to me…” [P17, 
Delayed, autologous reconstruction]
“…They [clinicians] make you feel like you’re the only one 
there in that office that day…They never rush you. You 
never felt like you were keeping them from someone else.” 
[P8, Immediate, implant-based reconstruction]
“…If you wanna discuss this again, you can call me, or you 
can come back, and we can go through it again. I think the 
most important thing is really just time and availability.” [C2]
Supplemental resources outside of the clinician/
patient conversation and consultation were useful to in-
crease engagement in SDM.
 “It’s a long book [received from a friend], but it takes you 
step-by-step, telling you what the different kinds of breast 
cancer are, and what that means to you…it was the best 
tool that anybody could give me.” [P1, Immediate, implant-
based reconstruction]
“I got online and Googled pictures, to see what that kind 
of reconstruction that I had looked like...” [P9, Delayed, 
autologous reconstruction]
“I came up with my decision…based off the information 
that I gathered off the internet, and just lookin’ at his 
[plastic surgeon’s] lil brochure.” [P4, Immediate, autolo-
gous and implant-based reconstruction]
 “…we have a webinar to view…We send them an email 
link ahead of time…we have a…packet that we also give 
them in writing that goes over all the risks.” [C11]
“For [SDM] to really work, I feel like they have to be a well-
informed patient. Whether that’s information that I’ve just 
provided, which can be overwhelming in one sitting, whether 
that’s information that they look up ahead of time…” [C16]
One caveat to the utility of supplemental resources was 
the credibility or applicability of the information accessed.
“I spent about five minutes on the internet. It scared me to 
death…If you want to call it a resource or a scare tactic, 
I’m not sure…” [P13, Immediate, implant-based recon-
struction]
 “…in the Googling and searching that I did online, I saw 
very little people—women of color that had had implants or 
reconstruction all together…Also, being larger… I didn’t 
quite know what that would translate like to a larger body.” 
[P10, Immediate, implant-based reconstruction]
“the patients…they take everything off of the Internet. It 
just causes so much more anxiety and so much pressure. I 
think that we need to actively push back against that with 
real conversations or descriptions from patients who’ve 
gone through the whole experience.” [C11]
DISCUSSION
Overall, clinician and patient stakeholders generally 
felt that SDM during PMBR choices was important. Some 
providers did an excellent job engaging patients in PMBR 
decisions and providing resources to support the decision 
process. However, this study suggests that SDM is variably 
implemented in practice, consistent with past research in 
other contexts.19,25,26 When SDM was not implemented, pa-
tients felt disappointed with the lack of information, partic-
ularly about potential PMBR risks. Clinicians acknowledged 
downplaying risks in some circumstances as well. Even in 
instances where knowledge was sufficient, power imbal-
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ance remained a barrier to participating in SDM.27 Patients 
often felt pressured to make choices, particularly when 
they felt that clinicians had age- or race-related biases re-
garding candidacy for PMBR. Some clinicians’ words were 
recalled by patients as being paternalistic, condescending, 
and dismissive. Many of these statements were quite alarm-
ing. Although there are situations where individual patient 
risk factors or treatment plans may limit available PMBR 
options, when these factors are not communicated clearly 
to patients, patients may feel less satisfied with their choic-
es and PMBR outcomes.28 In fact, many patients expressed 
decision regret when they were not engaged in PMBR dis-
cussions. Clinicians’ communication style and approach 
to patient engagement clearly impacted patients’ recall of 
their PMBR experience.
Stakeholders described supplemental information 
sought outside of the consultation as useful for support-
ing patients’ choices. Concordant with expectancy theo-
ry,29 frequently referenced information that was desired 
included representative and realistic pictures specific to 
the type of reconstruction, race and build of the individu-
al, highlighting scarring or lack thereof; and information 
from survivors about their experiences, specifically what to 
expect postoperatively. Representative photographs were 
particularly important for African American and older pa-
tients. Although previous studies have shown disparities in 
knowledge regarding and receipt of PMBR surgery by Af-
rican Americans,15,16 this study is the first to our knowledge 
to describe how older and African American women may 
feel excluded from conversations and resources about 
PMBR. SDM and patient-centered communication across 
all demographics may help address previously identified 
disparities in PMBR knowledge and outcomes.
Patient–clinician trust was also critical in supporting 
patient choice and decreasing decision regret, particu-
larly when patients and clinicians initially disagreed about 
PMBR. Patient stakeholders communicated a reluctance 
to disagree with clinicians, which may be attributed to fear 
that disagreement would not be socially acceptable.30 Cli-
nician stakeholders noted disagreements could be “disap-
pointing” or “frustrating.” When clinicians and patients 
successfully managed potential disagreements about 
PMBR choices through SDM, patients described feeling 
more confident in their choices and the patient–clinician 
relationship. An engaged care team, adequate time and 
availability, and supplemental information were all iden-
tified in this study as facilitators to SDM, and could be 
particularly useful tools during times of patient–clinician 
disagreement.
The results of this study should be viewed through a 
qualitative lens; although they provide in-depth percep-
tions that are both rich and meaningful, they do not 
necessarily reflect perceptions of all PMBR patients and 
clinicians. Additionally, patients who chose not to par-
ticipate may have been different and more disadvantaged 
with their reconstruction experience. As a result, the 
findings here may not capture the more extreme cases 
of breast reconstruction decisions. Recruitment of only 
plastic and reconstructive surgeons was done to seek ex-
pertise in how to counsel women about reconstruction op-
tions. However, this may have limited perspectives since, 
in some settings, breast surgeons may do the initial coun-
seling with patients about their reconstruction options. 
Although the surgeons were recruited nationally, patient 
and nurse stakeholders were recruited from a single aca-
demic institution.
Overall, these results suggest that interventions to 
support SDM may enhance decision quality and reduce 
decision regret about PMBR. Development of a DA that 
integrates patient-specific clinical features with patient 
preferences, and provides frequently sought information 
as identified by stakeholders, may facilitate a more stan-
dard approach to SDM for all patients, in a way that also 
respects patient diversity.31 Such interventions may help 
manage patient–clinician discussions and their relation-
ship during this preference-sensitive choice, ultimately 
improving patient-centered care for women with breast 
cancer contemplating breast reconstruction.
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